magnolol has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, GAS; El-Borady, OM; Elhabak, M; Mohamed, M; Mortada, N; Osman, R | 1 |
| Iqbal, F; Khan, M; Ma, T; Rasul, A; Yang, H; Yu, B; Zhang, K | 1 |
2 other study(ies) available for magnolol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Near IR responsive targeted integrated lipid polymer nanoconstruct for enhanced magnolol cytotoxicity in breast cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gold; Humans; Lignans; Metal Nanoparticles; Microscopy, Confocal; Oxazines; Particle Size; Photothermal Therapy; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Surface Properties; Trastuzumab; Vitamin E | 2020 |
Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways.
Topics: Adenocarcinoma; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Caspase 3; Cell Growth Processes; Down-Regulation; Enzyme Activation; Humans; Lignans; Mitochondria; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-bcl-2; S Phase; Signal Transduction; Stomach Neoplasms | 2012 |